NCT02139007View on ClinicalTrials.gov

Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Osteoporosis
Interventions
DRUG

Alendronate

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02139007 - Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study | Biotech Hunter | Biotech Hunter